Specimen for Anti-MOG Antibody Testing
Serum is the recommended specimen of choice for anti-MOG antibody testing. 1
Primary Specimen: Serum
According to international consensus guidelines, serum is the specimen of choice for detecting MOG-IgG antibodies 1. This recommendation is based on the fact that MOG-IgG is produced predominantly extrathecally (outside the central nervous system), resulting in higher antibody titers in serum compared to cerebrospinal fluid.
Sample Handling Requirements:
- Shipment at 4°C or on dry ice is advisable if samples do not arrive at the testing laboratory within 1-2 days 1
- This ensures antibody stability during transport
Cerebrospinal Fluid (CSF): Limited Role
CSF testing is not usually required for MOG antibody detection 1. The guidelines explicitly state that CSF has lower MOG-IgG titers than serum due to the extrathecal production of these antibodies.
When CSF May Be Considered:
CSF testing is potentially helpful only in rare, selected cases, such as:
- Strong background interference due to co-existing high-titer non-MOG serum antibodies 1
- When serum results are equivocal but clinical suspicion remains high
If CSF is tested, the same handling requirements apply (shipment at 4°C or on dry ice) 1.
Testing Methodology Considerations
The guidelines emphasize that cell-based assays (CBA) using serum are the current gold standard 1, 2. The assay must employ:
- Full-length human MOG as the target antigen
- Fc-specific (or IgG1-specific) secondary antibodies to avoid cross-reactivity with IgM and IgA antibodies
Testing should focus on MOG-IgG specifically, as testing for MOG-IgM or MOG-IgA is currently not recommended due to unknown clinical relevance of isolated results 1.
Critical Timing Considerations
Timing of serum collection matters because MOG-IgG concentrations fluctuate based on:
- Disease activity: Higher concentrations during acute attacks versus remission 1
- Treatment status: Lower concentrations while on immunosuppression 1
- Post-treatment effects: Antibodies may transiently vanish after plasma exchange 1
When to Retest:
If initial serum MOG-IgG is negative but MOGAD is still suspected, retest during:
- Acute attacks
- Treatment-free intervals
- 1-3 months after plasma exchange or IVIG 1
Common Pitfalls to Avoid
- Do not rely on CSF as the primary specimen - you will miss cases due to lower titers
- Avoid testing during or immediately after plasma exchange - may yield false negatives
- Do not use peptide-based ELISA or Western blot - these are insufficiently specific and obsolete 1
- Ensure proper sample handling - antibody degradation can occur with improper storage/transport